Literature DB >> 7468621

Nosocomial infections--a 1980 view: progress, priorities and prognosis.

T C Eickhoff.   

Abstract

Following a brief historic perspective, this review highlights the progress that has been made in the field of nosocomial infections in the past decade. Scientific progress has been made in a few efficacy studies, the determinative role of the host, concepts of immunoincompetence, emerging pathogens, such as Legionnella pneumophila, the epidemiology of antimicrobial drug resistance and concepts of chemoprophylaxis. Major advances have been made in preventing a few specific nosocomial infections such as hepatitis B. The evolving roles of infection control practitioners and hospital epidemiologists represent important progress in meeting manpower needs. Major failures of the past decade include the continuing absence of an acceptable scientific basis for infection control, the lack of standards for hospital infection control and the consequent inability to carry out effective education. Major challenges in the 1980s will be to determine what is effective and what is not in infection control activities, and to focus control activities and recommendations more sharply.

Entities:  

Mesh:

Year:  1981        PMID: 7468621     DOI: 10.1016/0002-9343(81)90776-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Survival of gram-negative and gram-positive bacteria artificially applied on the hands.

Authors:  P P Gontijo Filho; M Stumpf; C L Cardoso
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

2.  Surveillance of nosocomial infections by computer analysis of positive culture rates.

Authors:  R B Schifman; R A Palmer
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

Review 3.  Clinical pharmacological and therapeutic considerations in general intensive care. A review.

Authors:  M L Farina; M Bonati; G Iapichino; A Pesenti; F Procaccio; L Boselli; M Langer; A Graziina; G Tognoni
Journal:  Drugs       Date:  1987-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.